Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 691–705 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3558 SOX3 Gene Panhypopituitarism, X-Linked Genetic Test This test identifies pathogenic sequence variants, deletions, and duplications in the SOX3 gene associated with X-linked panhypopituitarism.	Peripheral whole blood (EDTA tube), extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SOX3 gene", "Copy number variants (deletions/duplications) in the SOX3 gene"] Parameters [] Preparation ["No fasting required", "No need to stop medications"] Indications ["Clinical suspicion of X-linked panhypopituitarism", "Family history suggestive of X-linked inheritance pattern", "Carrier screening in females"] Measurement technique Confirm with laboratory Codes LOINC: 81464-6 ICD-10: E23.0 Clinical summary This test identifies pathogenic sequence variants, deletions, and duplications in the SOX3 gene associated with X-linked panhypopituitarism.
TEST-4708 SP7 Gene Osteogenesis Imperfecta Type 12 Genetic Test This test detects pathogenic variants in the SP7 gene to diagnose autosomal recessive osteogenesis imperfecta type XII (OI-XII).	Whole blood (EDTA) or dried blood spot (FTA card)	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SP7 gene", "Copy number changes in the SP7 gene"] Parameters [] Preparation [] Indications ["Clinical and radiological findings suggesting OI type XII", "Familial genetic counseling for OI"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q78.0 Clinical summary This test detects pathogenic variants in the SP7 gene to diagnose autosomal recessive osteogenesis imperfecta type XII (OI-XII).
TEST-5735 SPART (SPG20) Gene Genetic Test This test detects pathogenic variants in the SPG20 gene associated with hereditary spastic paraplegia (Troyer syndrome).	Whole blood (EDTA), dried blood spot (FTA card), or extracted DNA	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPG20 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No fasting required", "No medication adjustments needed unless directed by physician"] Indications ["Suspected hereditary spastic paraplegia (Troyer syndrome)", "Progressive lower limb spasticity", "Family history of spastic paraplegia"] Measurement technique Confirm with laboratory Codes LOINC: 48817-2 ICD-10: G11.4 Clinical summary This test detects pathogenic variants in the SPG20 gene associated with hereditary spastic paraplegia (Troyer syndrome).
TEST-5758 SPAST Gene (SPG4) Next-Generation Sequencing (NGS) Genetic Test This test evaluates the SPAST gene for pathogenic mutations associated with hereditary spastic paraplegia type 4 (HSP-SPG4).	Peripheral whole blood (EDTA), extracted DNA, or FTA card sample	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPAST gene", "Single nucleotide variants", "Indels", "Copy number changes"] Parameters [] Preparation [] Indications ["Suspected hereditary spastic paraplegia (HSP)", "Family history of HSP", "Differentiation from other neurological disorders"] Measurement technique Confirm with laboratory Codes LOINC: 95803-7 ICD-10: G11.4 Clinical summary This test evaluates the SPAST gene for pathogenic mutations associated with hereditary spastic paraplegia type 4 (HSP-SPG4).
TEST-3608 SPINK1 Gene Pancreatitis Next-Generation Sequencing (NGS) Genetic Test This genetic test evaluates the SPINK1 gene for pathogenic variants associated with hereditary pancreatitis and pancreatic cancer risk.	Standard Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPINK1 gene"] Parameters [] Preparation ["Do not discontinue prescribed medications without consulting your referring physician", "Avoid blood transfusions within two weeks prior to sample collection", "Inform your genetic counsellor about any recent illness or immunosuppressive therapy"] Indications ["Individuals with a family history of pancreatitis or pancreatic cancer", "Individuals with unexplained recurrent pancreatitis", "Individuals with early-onset pancreatitis without identifiable causes"] Measurement technique Confirm with laboratory Codes LOINC: 21674-2 ICD-10: K86.1 Clinical summary This genetic test evaluates the SPINK1 gene for pathogenic variants associated with hereditary pancreatitis and pancreatic cancer risk.
TEST-1093 Spinocerebellar Ataxia (SCA) Genetic Panel (Types 1, 2, 3, 6, 7, 10 & 12) Test This test identifies specific genetic mutations associated with Spinocerebellar Ataxia (SCA) subtypes 1, 2, 3, 6, 7, 10, and 12.	Peripheral Whole Blood	5-7 Business Days	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Abnormal trinucleotide repeat expansions", "Specific SCA-associated genes (SCA1, SCA2, SCA3, SCA6, SCA7, SCA10, SCA12)"] Parameters [] Preparation ["No fasting required", "No special preparation needed"] Indications ["Clinical suspicion of hereditary ataxia", "Confirmation of SCA diagnosis", "Prognostic information", "Family planning and genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 86210-1 ICD-10: G11.0, Z13.71 Clinical summary This test identifies specific genetic mutations associated with Spinocerebellar Ataxia (SCA) subtypes 1, 2, 3, 6, 7, 10, and 12.
TEST-3075 Spinocerebellar Ataxia Type 3 (SCA3) ATXN3 Gene Mutation Analysis Test This diagnostic test evaluates the ATXN3 gene for CAG trinucleotide repeat expansions, which are the cause of Spinocerebellar Ataxia Type 3.	Whole blood	4–5 business days (sample collection Tuesday before 11 AM, report Saturday)	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansion in the ATXN3 gene", "Exact repeat length"] Parameters [{"name": "CAG Repeat Length", "reference_range": "Normal: Preparation ["No dietary restrictions are needed", "Complete the Genomics Clinical Information Requisition Form (Form 20)"] Indications ["Diagnosis confirmation for suspected SCA3", "Pre-symptomatic screening for at-risk individuals", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 21660-2 ICD-10: G11.2 Clinical summary This diagnostic test evaluates the ATXN3 gene for CAG trinucleotide repeat expansions, which are the cause of Spinocerebellar Ataxia Type 3.
TEST-4757 SPRED1 Gene Neurofibromatosis Type 1-Like Syndrome (Legius Syndrome) Genetic Test This genetic test analyzes the SPRED1 gene to identify pathogenic variants associated with Legius syndrome, a condition mimicking Neurofibromatosis Type 1.	Whole blood (EDTA), extracted DNA, or FTA card blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPRED1 gene", "Full coding sequence of SPRED1 gene (100% exons ±20 bp intronic boundaries)"] Parameters [{"name": "SPRED1 Gene Coverage", "reference_range": "100% exons ±20 bp intronic boundaries"}] Preparation ["No fasting required", "Provide complete clinical history and pedigree chart from pre-test genetic counselling session"] Indications ["Differential diagnosis between Neurofibromatosis Type 1 and Legius Syndrome", "Individuals with clinical features suggestive of NF1 but negative NF1 genetic testing", "Family members of individuals identified with a SPRED1 pathogenic variant"] Measurement technique Confirm with laboratory Codes LOINC: 95003-0 ICD-10: Q85.0 Clinical summary This genetic test analyzes the SPRED1 gene to identify pathogenic variants associated with Legius syndrome, a condition mimicking Neurofibromatosis Type 1.
TEST-1958 SPRED1 Gene Neurofibromatosis Type 1‑Like Syndrome (Legius Syndrome) Genetic Test This test evaluates the SPRED1 gene for variants associated with Legius syndrome, an NF1-like disorder.	Peripheral whole blood (EDTA tube or FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SPRED1 gene coding region variants", "Pathogenic variants associated with Legius syndrome"] Parameters [] Preparation [] Indications ["Diagnosis of Legius syndrome", "Evaluation of individuals with clinical features suggestive of Legius syndrome", "Genetic counseling for families with a history of Legius syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 77639-7 ICD-10: Q85.02, Z15.09, Z14.8 Clinical summary This test evaluates the SPRED1 gene for variants associated with Legius syndrome, an NF1-like disorder.
TEST-3342 SRP72 Gene Sequencing for Bone Marrow Failure Syndrome Type 1 Test This diagnostic test evaluates the SRP72 gene for pathogenic variants associated with autosomal recessive bone marrow failure syndrome type 1 (BMFS1).	Whole blood (3–5 mL in EDTA tube), Extracted DNA, or FTA card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SRP72 gene"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "Inform the laboratory if you have recently received a blood transfusion"] Indications ["Diagnosis of Bone Marrow Failure Syndrome Type 1 (BMFS1)", "Familial risk stratification for BMFS1"] Measurement technique Confirm with laboratory Codes LOINC: 101430-3 ICD-10: D61.09 Clinical summary This diagnostic test evaluates the SRP72 gene for pathogenic variants associated with autosomal recessive bone marrow failure syndrome type 1 (BMFS1).
TEST-3821 SS18L1 Gene Amyotrophic Lateral Sclerosis and CREST-Related Genetic Test This test identifies pathogenic variants within the SS18L1 gene associated with Amyotrophic Lateral Sclerosis (ALS) and CREST syndrome.	Whole Blood (Peripheral), Saliva, or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SS18L1 gene", "Copy Number Variations (CNV) in SS18L1"] Parameters [] Preparation ["No fasting required", "May continue regular medications"] Indications ["Diagnosis of ALS", "Diagnosis of CREST syndrome", "Risk assessment for ALS", "Risk assessment for CREST syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G12.21, M34.1 Clinical summary This test identifies pathogenic variants within the SS18L1 gene associated with Amyotrophic Lateral Sclerosis (ALS) and CREST syndrome.
TEST-4979 ST14 Gene Genetic Test for Autosomal Recessive Congenital Ichthyosis Type 11 (ARCI11) This diagnostic test evaluates the ST14 gene for variants associated with autosomal recessive congenital ichthyosis type 11 (ARCI11).	Whole Blood (EDTA) or Dried Blood Spot (FTA card)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ST14 gene coding exons", "ST14 gene splice junctions"] Parameters [] Preparation ["No fasting required", "Continue regular medication and skincare routine"] Indications ["Suspected diagnosis of ARCI11", "Family history of ARCI11", "Need for genetic counselling regarding ARCI11"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q80.8 Clinical summary This diagnostic test evaluates the ST14 gene for variants associated with autosomal recessive congenital ichthyosis type 11 (ARCI11).
TEST-6021 ST6GAL2 Gene Beta-Galactoside Alpha-2,6-Sialyltransferase 2 Deficiency Genetic Test This genetic test identifies pathogenic variants in the ST6GAL2 gene, confirming or ruling out Beta-Galactoside Alpha-2,6-Sialyltransferase 2 deficiency.	Whole blood (peripheral), extracted DNA, or FTA card spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ST6GAL2 gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Suspected Beta-Galactoside Alpha-2,6-Sialyltransferase 2 deficiency", "Congenital disorder of glycosylation (CDG) investigation", "Family planning for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 94473-4 ICD-10: E77.8 Clinical summary This genetic test identifies pathogenic variants in the ST6GAL2 gene, confirming or ruling out Beta-Galactoside Alpha-2,6-Sialyltransferase 2 deficiency.
TEST-2510 STAC3 Gene Native American Myopathy Genetic Test This test detects pathogenic variants in the STAC3 gene associated with Native American myopathy.	Whole Blood or Buccal Swab	21 - 28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["STAC3 gene variants", "SNVs", "Small Indels", "Copy-Number Variants"] Parameters [] Preparation ["No fasting required", "Inform genetic team of anticoagulant therapy"] Indications ["Diagnosis of Native American myopathy", "Perioperative safety assessment", "Multidisciplinary care planning", "Genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G71.2 Clinical summary This test detects pathogenic variants in the STAC3 gene associated with Native American myopathy.
TEST-4994 STAMBP Gene Microcephaly‑Capillary Malformation Syndrome NGS Test This test identifies pathogenic variants in the STAMBP gene associated with microcephaly‑capillary malformation syndrome.	Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Saliva (Oragene DNA Kit)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["STAMBP gene coding regions", "Pathogenic variants"] Parameters [] Preparation ["No special preparation such as fasting is required"] Indications ["Clinical suspicion of microcephaly‑capillary malformation syndrome", "Family history of the syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 92868-0 ICD-10: Q87.2 Clinical summary This test identifies pathogenic variants in the STAMBP gene associated with microcephaly‑capillary malformation syndrome.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.